MEDI9253
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for MEDI9253, covering 2025-06-24 to 2025-06-24. Get the full timeline:
Most recent: Clinical Trial Update: A Study of MEDI9253 in Combination With Durvalumab in Select Solid Tumors [Phase 1]